Found: 1
Select item for more details and to access through your institution.
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
- Published in:
- European Child & Adolescent Psychiatry, 2006, v. 15, n. 2, p. 105, doi. 10.1007/s00787-006-0506-y
- By:
- Publication type:
- Article